Press Releases

May 19, 2026

New

DNAnexus Scales AI-Driven Capabilities

17-Year Multiomics Pioneer Powers Next Era of Precision Health

May 07, 2026

DNAnexus Wins MedTech Breakthrough’s PharmaTech Innovation Award

Enterprise Leading Orchestration Platform Honored for AI-Enabled Infrastructure and Next-Gen Digital Health & Medical Technology

May 07, 2026

Longitude Prize on ALS Announces Stage 1 Discovery Award Winners

Meet the Discovery Awardees of the Longitude Prize on ALS, awarded £100,000 each, as well as access to the Prize datasets and a technical support package to drive their computational work. These 20 pioneering, global and multidisciplinary teams are using cutting-edge AI to unlock the complexity of ALS.

November 10, 2025

EpiCypher Launches CUTANA® Cloud, a Powerful Epigenomic Data Analysis Platform

EpiCypher’s new bioinformatics platform, powered by DNAnexus, accelerates data analysis for leading chromatin mapping technologies including CUT&RUN and CUT&Tag.

October 22, 2025

DNAnexus Honored with Frost & Sullivan’s 2025 Technology Innovation Leadership Award

DNAnexus earned recognition from Frost & Sullivan for its leadership in precision health informatics. The award highlights its groundbreaking platform for integrating complex clinical, multi-omics, and real-world data to deliver secure, actionable insights.

View More →

News

May 29, 2026

New

Immunai, AstraZeneca Expand Partnership, Rancho Biosciences Releases Multi-omics Datasets, Dotmatics AI Co-Scientist

By bridging the gap between raw multimodal data and clinical discovery, DNAnexus enables health leaders to operationalize AI across critical workflows with full regulatory readiness.

May 26, 2026

Programming biology: next-gen AI firms raise billions to design better medicines

Faster drug discovery, optimized drug design, even programmable therapeutics: AI is impacting R&D. Data and development bottlenecks remain.

May 19, 2026

DNAnexus AI Products

DNAnexus has launched a number of software products and enhancements that are enabled by artificial intelligence.

May 01, 2026

How are companies distinguishing between “moonshot” automation and validated digital tools that can be deployed today?

Todd Oakland, Ph.D., Senior Vice President, General Manager, Biopharma RX/DX, DNAnexus, joins a roundtable of experts to discuss the pace of technological innovation and how to tell when a tool is production-ready.

March 31, 2026

AI-led selloff in contract research firms may be misjudging disruption risk

Shares of contract research organizations have tumbled on fears that advances in artificial intelligence could allow drugmakers to take clinical trial work in-house, but industry experts say the selloff overestimates how far the technology can replace the sector's core capabilities.

View More →